Perrigo (NYSE:PRGO) Rating Increased to Strong-Buy at Wall Street Zen

by · The Cerbat Gem

Wall Street Zen upgraded shares of Perrigo (NYSE:PRGO – Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Saturday morning,Wall Street Zen reports.

Separately, Weiss Ratings raised Perrigo from a “sell (d-)” rating to a “sell (d)” rating in a research report on Thursday, August 6th. One investment analyst has rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $19.33.

View Our Latest Stock Report on Perrigo

Perrigo Stock Performance

Shares of PRGO stock opened at $13.59 on Friday. Perrigo has a one year low of $9.23 and a one year high of $22.65. The company has a debt-to-equity ratio of 1.31, a quick ratio of 1.32 and a current ratio of 2.32. The company has a 50 day moving average price of $12.62 and a 200 day moving average price of $11.41. The firm has a market capitalization of $1.89 billion, a price-to-earnings ratio of -1.09, a price-to-earnings-growth ratio of 1.55 and a beta of 0.59.

Perrigo (NYSE:PRGO – Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.50 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.11. Perrigo had a negative net margin of 41.85% and a positive return on equity of 11.25%. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.02 billion. During the same quarter last year, the business earned ($0.06) EPS. Perrigo’s revenue for the quarter was down 3.1% on a year-over-year basis. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. Sell-side analysts anticipate that Perrigo will post 2.18 EPS for the current year.

Perrigo Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 15th. Stockholders of record on Friday, August 28th were paid a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a dividend yield of 8.5%. The ex-dividend date of this dividend was Friday, August 28th. Perrigo’s dividend payout ratio (DPR) is currently -9.27%.

Institutional Trading of Perrigo

Institutional investors have recently added to or reduced their stakes in the business. EverSource Wealth Advisors LLC increased its holdings in Perrigo by 116.0% in the 4th quarter. EverSource Wealth Advisors LLC now owns 1,888 shares of the company’s stock valued at $26,000 after purchasing an additional 1,014 shares in the last quarter. Huntington National Bank lifted its stake in shares of Perrigo by 99.9% during the fourth quarter. Huntington National Bank now owns 4,741 shares of the company’s stock worth $66,000 after purchasing an additional 2,369 shares in the last quarter. KBC Group NV boosted its position in shares of Perrigo by 61.3% in the first quarter. KBC Group NV now owns 6,283 shares of the company’s stock worth $67,000 after buying an additional 2,388 shares during the period. Parvin Asset Management LLC purchased a new stake in shares of Perrigo in the second quarter worth about $79,000. Finally, Covestor Ltd grew its stake in shares of Perrigo by 14.4% in the fourth quarter. Covestor Ltd now owns 8,991 shares of the company’s stock valued at $125,000 after buying an additional 1,129 shares in the last quarter. 95.91% of the stock is owned by hedge funds and other institutional investors.

About Perrigo

(Get Free Report)

Perrigo Company plc is a global consumer self-care company that develops, manufactures and markets over-the-counter (OTC) products and other nonprescription health and wellness products. Its portfolio spans consumer health categories including pain relief, allergy and cold remedies, digestive health, skin care, oral care, vitamins and supplements, and women’s health.

The company sells products under both its own brands and retailer-owned store brands through pharmacies, supermarkets, mass merchants, e-commerce channels and other outlets.

Featured Stories